Global active pharmaceutical ingredient market is expected to undergo robust growth during the forecast period, 2024-2028. The high adoption rate of generic drugs and increasing demand for speciality medicines are bolstering the growth of the market. The expansion of
Moreover, rapid
Global active pharmaceutical ingredient market is segmented into
Regionally, North America dominated the global
Major companies operating in global active pharmaceutical ingredient market include Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Merck & Co., Inc., GlaxoSmithKline Plc, Novartis International AG, F. Hoffmann-La Roche AG, Sanofi S.A., Eli Lilly and Company, and AbbVie Inc. The market players are investing on new product launches through extensive R&D activities. They are also undergoing partnerships, merger and collaborations to increase their share in global market.
Objective of the Study
·
·
·
·
·
Download Free Sample Report
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of active pharmaceutical ingredient manufacturers across the globe. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the companies which could not be identified due to the limitations of secondary research.
Market insights research calculated global active pharmaceutical ingredient market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. Market insights research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by Market insights research.
Key Target Audience
- Active pharmaceutical ingredient companies, vendors, end users, and others.
- Government bodies such as regulating authorities and policy makers
- Organizations, industry associations, forums and alliances related to active pharmaceutical ingredient
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as active pharmaceutical ingredient companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Attribute | Details |
Base Year | 2022 |
Historical Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023E-2028F |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Type of Synthesis · Type pf Manufacturer · Route of Administration · Type of Drugs · Therapeutic Application · Region |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia; Germany, France, United Kingdom, Spain, Italy; South Africa, UAE, Saudi Arabia; Brazil, Colombia; |
Key companies profiled | Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Merck & Co., Inc., GlaxoSmithKline Plc, Novartis International AG, F. Hoffmann-La Roche AG, Sanofi S.A., Eli Lilly and Company, and AbbVie Inc. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |